MatrixView [ASX: MVU] has been awarded a European Patent for its proprietary ABO technology.

The patent has been awarded for the company's proprietary Advanced Binary Optimisation (ABO) technology, which allows MatrixView's healthcare products to provide lossless data streams.

ABO is the backbone of MatrixView's healthcare products - such as its tele-radiology solution - where high-resolution, highly accurate data streams are required.

Its key feature is an ability to provide mathematically lossless data management – the ability to compress large amounts of data without losing any of that data, critical in medical applications.

The company has also applied for patents for ABO from the US.